QUACX
Price
$27.26
Change
+$0.09 (+0.33%)
Updated
Sep 18 closing price
VISGX
Price
$73.84
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
Ad is loading...

QUACX vs VISGX

Header iconQUACX vs VISGX Comparison
Open Charts QUACX vs VISGXBanner chart's image
AB Small Cap Growth C
Price$27.26
Change+$0.09 (+0.33%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Growth Index I
Price$73.84
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
QUACX vs VISGX Comparison Chart
Loading...
VS
QUACX vs. VISGX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QUACX is a Buy and VISGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 35.3B vs. QUACX (3.78B). VISGX pays higher dividends than QUACX: VISGX (0.55) vs QUACX (0.00). QUACX was incepted earlier than VISGX: QUACX (31 years) vs VISGX (26 years). QUACX is a more actively managed with annual turnover of: 65.00 vs. VISGX (19.00). QUACX has a lower initial minimum investment than VISGX: QUACX (2500) vs VISGX (3000). QUACX annual gain was more profitable for investors over the last year : 22.61 vs. VISGX (18.84). VISGX return over 5 years is better than : 40.95 vs. QUACX (-15.20).
QUACXVISGXQUACX / VISGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years26 years-
Gain YTD14.8358.795169%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets3.78B35.3B11%
Annual Yield % from dividends0.000.55-
Returns for 1 year22.6118.84120%
Returns for 3 years-33.86-9.45358%
Returns for 5 years-15.2040.95-37%
Returns for 10 years-29.94117.46-25%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVOK4.360.14
+3.29%
Evoke Pharma, Inc.
AXR26.670.54
+2.07%
AMREP Corp
HBM7.550.13
+1.75%
Hudbay Minerals
FMS20.88-0.05
-0.24%
Fresenius Medical Care AG
MREO3.95-0.55
-12.22%
Mereo BioPharma Group plc